Epstein-Barr virus modulates 5-lipoxygenase product synthesis in human peripheral blood mononuclear cells

Blood

Volumn 89, Issue 6, 1997, Pages 2122-2130

  Gosselin, Jean ^a   Borgeat, Pierre ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CALCIMYCIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE C4; ZYMOSAN;

ARTICLE; CELL STIMULATION; CELL SUSPENSION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; EPSTEIN BARR VIRUS; FATTY ACID SYNTHESIS; HUMAN; HUMAN CELL; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

EID: 0030979945     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.6.2122     Document Type: Article

References (50)

1. Borgeat P, Samuelsson B: Metabolism of arachidonic acid in polymorphonuclear leukocytes. Effects of ionophore A23187. Proc Natl Acad Sci USA 76:2148, 1979
2. 4. Clin Biochem 23:459, 1990
3. Lewis RA, Austin KF, Soberman RJ: Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 323:645, 1990
4. 4 induces human suppressor lymphocytes. Biochem Biophys Res Commun 108:1531, 1982
5. 4 in human lymphocyte cultures. Prostaglandins Leukot Med 23:207, 1986
6. Rola-Pleszczynski M, Lemaire I: Leukotrienes augment interleukin production by human monocytes. J Immunol 135:3958, 1985
7. Rola-Pleszczynski M: Immunoregulation by leukotrienes and other lipoxygenase metabolites. Immunol Today 6:302, 1985
8. Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Harel-Bellan A, Farrar WL: Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci USA 86:621, 1989
9. 4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. Chest 104:763, 1993
10. 2 release from HIV-infected mononuclear phagocytes. Virology 208:590, 1995
11. 4 in respiratory tract during acute viral infection. J Pediatr 112:218, 1988
12. Volovitz B, Welliver RC, de Castro G, Krystorik DA, Ogra PL: The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: Role in obstructive airway disease. Pediatr Res 24:504, 1988
13. Ananaba GA, Anderson LJ: Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophage like cell line. J Virol 65:5052, 1991
14. Kimpen JLL, Garofalo R, Welleiver RC, Ogra PL: Activation of human eosinophils in vitro by respiratory syncytial virus. Pediatr Res 32:160, 1992
15. 4-hydrolase gene which is increased after simian-virus-40 transformation. Eur J Biochem 191:27, 1990
16. Gosselin J, Menezes J, D'Addario M, Hiscott J, Flamand L, Lamoureux G, Oth D: Inhibition of tumor necrosis faαctor-α transcription by Epstein-Barr virus. Eur J Immunol 21:203, 1991
17. Gosselin J, Flamand L, D'Addario M, Hiscott J, Menezes J: Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. J Clin Invest 89:1849, 1992
18. Gosselin J, Flamand L, D'Addario M, Hiscott J, Stefanescu I, Ablashi DV, Gallo RC, Menezes J: Modulatory effects of Epstein-Barr, herpes simplex and human herpes-6 viral infection and coinfection on cytokine synthesis. A comparative study. J Immunol 149:181, 1992
19. Beaulieu AD, Paquin R, Gosselin J: Epstein-Barr virus modulates de novo protein synthesis in human neutrophils. Blood 86:2789, 1995
20. Miltenyl S, Müller W, Weichel W, Radbruch A: High gradient magnetic cell separation with MACS. Cytometry 11:231, 1990
21. Surette ME, Nadeau M, Borgeat P, Gosselin J: Priming of human peripheral blood mononuclear cells with lipopolysaccharides for enhanced arachidonic acid release and leukotriene synthesis. J Leukoc Biol 59:709, 1996
22. Menezes J, Leibold W, Klein G: Biological differences between Epstein-Barr (EBV) strains with regard to lymphocyte transformation ability, superinfection and antigen induction, Exp Cell Res 92:478, 1975
23. 2+ ionophore A23187 in neutrophils using 15-hydroperoxy-eicosatetraeonoate as a substrate. Biochem J 280:379, 1991
24. Borgeat P, Picard S, Vallerand P, Bourgoin S, Odeimat A, Sirois P, Poubelle PE: Automated on-line extraction and profiling of lipoxygenase products of arachidonic acid by high-performance liquid chromatography. Methods Enzymol 187:98, 1990
25. Surette ME, Palmantier R, Gosselin J, Borgeat P: Lipopolysaccharides prime whole human blood and isolated neutrophils for the increased synthesis of 5-lipoxygenase products by enhancing arachidonic acid availability: Involvement of the CD14 antisera. J Exp Med 178:1347, 1993
26. 2, 5-lipoxygenase, and FLAP at the nuclear membrane of A23187-stimulated human neutrophils. Eur J Biochem 238:250, 1996
27. 2+ membrane binding but not for catalytic activity. Biochem Biophys Res Commun 184:118, 1992
28. 2+-independent catalytic domain. J Biol Chem 269:18239, 1994
29. 2 is phosphorylated and activated by MAP kinase. Cell 72:269, 1993
30. 2 by p42 microtubule-associated protein-2 kinase and protein kinase C. J Biol Chem 268:1960, 1993
31. 2. Biochemistry 32:5935, 1993
32. 2 as mediator of the enhanced arachidonic acid release from dimethyl sulphoxide differentiated U937 cells. Biochem Pharmacol 50:1893, 1995
33. 2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J Biol Chem 269:15619, 1994
34. Hedrick JA, Watry D, Speiser C, O'Donnell P, Lambris JD, Tsoukas CD: Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2. J Immunol 22:1123, 1992
35. Watry D, Hedrick JA, Siervo S, Rhodes G, Lamberti JJ, Lambris JD, Tsoukas CD: Infection of human thymocytes by Epstein-Barr virus. J Exp Med 173:971, 1991
36. Sauvageau G, Stocco R, Kasparian S, Menezes J: Epstein-Barr virus receptor expression in human CD8+ (cytotoxic/suppressor) T lymphocytes. J Gen Virol 71:371, 1990
37. Bejarano MT, Masucci MG, Morgan A, Morein B, Klein G, Klein E: Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation. J Virol 63:1398, 1990
38. 4 in the immune system. Int J Immunopharmacol 14:441, 1992
39. Elsner J, Kaever V, Emmendorffer A, Breidenbach T, Lohmann-Matthes ML, Roseler J: Heterogeneity in the mobilization of cytoplasmic calcium by human polymorphonuclear leukocytes in response to fMLP, C5a and IL-8/NAP-1. J Leukoc Biol 51:77, 1992
40. Clancy RM, Dahinden CA, Hugly TE: Arachidonate meatabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation. Proc Natl Acad Sci USA 80:7200, 1983
41. 2+ ionophore A23187. Biochem J 280:379, 1991
42. 2. EMBO J 11:4917, 1992
43. 2 in human neutrophil cytosol. Biochim Biophys Acta 1168:37, 1993
44. 2 in granules and secrete active enzymes in response to soluble stimuli. Biochem Biophys Res Commun 208:650, 1995
45. Rouzer CA, Kargman S: Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J Biol Chem 263:10980, 1988
46. 4 by human neutrophils in response to PAF-acether. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation. J Immunol 146:1204, 1991
47. DiPersio JF, Naccache PH, Borgeat P, Gasson JC, Nguyen MH, McColl SR: Characterization of the priming effects of human granulocyte-macrophage colony-stimulating factor on human neutrophil leukotriene synthesis. Prostaglandins 36:673, 1988
48. Dahinden CA, Zingg J, Maly FE, de Weck AL: Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5a and fMLP as second signals. J Exp Med 167:1281, 1988
49. 2. J Clin Invest 93:1583, 1994
50. 7 in human neutrophils. Biochem J 313:503, 1996